Jobless Claims Indicate No One Is Getting Fired Anymore
No one is getting fired anymore. The U.S. Department of Labor released its reading on weekly jobless claims, which fell by 2,000 to a mere 210,000. This number used to run closer to and…
No one is getting fired anymore. The U.S. Department of Labor released its reading on weekly jobless claims, which fell by 2,000 to a mere 210,000. This number used to run closer to and…
The top analyst upgrades, downgrades and initiations seen on Thursday include Aetna, Analog Devices, Lowe's, Merck, Pfizer, Plug Power, Qualcomm and Target.
If you thought that Federal Reserve’s FOMC meeting for July 31 and August 1 was all over and done, guess again. Wednesday brought the release of the FOMC minutes. Despite the information being…
How on earth can analysts and investors maintain a positive view on gold miners? Is there still value in them even if the underlying commodity is in the toilet?
Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team at Bank of America Merrill Lynch.
The top analyst upgrades, downgrades and initiations seen from Wednesday include AT&T, CenturyLink, MercadoLibre, Netflix, Starbucks, Tiffany, TJX Companies and YRC Worldwide.
Too many people procrastinate about investing for their future. Many think they just cannot afford to invest, and many people just don't know how.
The top analyst upgrades, downgrades and initiations seen on Tuesday include Aerojet Rocketdyne, Apple, ADP, Honeywell, 3M, NeoGenomics, Paychex, Symantec and Tesla.
It might seem fitting to wonder whether J.C. Penney or Sears ultimately will fail first, but first one of these two fallen retail giants will end up a classic penny stock first.
The top analyst upgrades, downgrades and initiations seen on Monday include Applied Materials, Baker Hughes, Bloom Energy, Constellation Brands, Deere, JC Penney, Kroger, Nike and Tesla.
24/7 Wall St. has identified several biotech analyst calls from Wall Street wherein the analysts are projecting upside of 100% to about 400%.
J.C. Penney is in the midst of a crisis. It's looking ever closer to the time for J.C. Penney as a stock to be considered "The Penny."
One key analyst sees high growth in what many outsiders may not have considered to be within Lululemon's traditional market.
Canopy Growth has become a benchmark for the emerging legalization and medical cannabis segment, and a fresh investment from Constellation Brands just greatly increased its market value.
Sometimes activist investors just seem desperate to get a share price up but seem to have very little to really add. With Symantec, the activist investor community easily could score a large victory for…
The include top analyst upgrades, downgrades and initiations seen from Thursday AVEO Pharmaceuticals, Boeing, Canopy Growth, Coty, Kimberly-Clark, Lululemon Athletica, Macy's, Sysco and Teladoc Health.
The U.S. Department of Labor has released data indicating that nonfarm labor productivity rose by 2.9% in the second quarter of 2018. This was the strongest productivity gain in over three years.
The latest monthly Merrill Lynch RIC Report is quite favorable on the health care sector as an opportunity for investors. Here we identify some of the top health care picks.
The more recent observations about Buffett's portfolio changes coming into mid-2018 have been quite different than many of the historic and traditional Buffett picks.
Tesla's board of directors has formed a special committee made up of three independent directors to act on behalf of the company in connection with any go-private transaction.